Minerva Neurosciences, Inc. Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense
Minerva Neurosciences, Inc. (NERV) reported Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-11.
Financial Statements › Expense Statement
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense · last filed 2026-03-11
- Minerva Neurosciences, Inc. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2014-12-31 was $0.00.
- Minerva Neurosciences, Inc. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2014-09-30 was $0.00.
- Minerva Neurosciences, Inc. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2014-06-30 was $0.00.
- Minerva Neurosciences, Inc. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2013-06-30 was $0.00.
- Minerva Neurosciences, Inc. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2025 was $0.00.
- Minerva Neurosciences, Inc. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2024 was $0.00.
- Minerva Neurosciences, Inc. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2023 was $0.00.
- Minerva Neurosciences, Inc. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2022 was $0.00.
| Period end | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 3 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 6 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 9 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-11 | |||
| 2024-12-31 | $0.00 10-K · filed 2026-03-11 | |||
| 2023-12-31 | $0.00 10-K · filed 2025-02-25 | |||
| 2022-12-31 | $0.00 10-K · filed 2024-02-22 | |||
| 2021-12-31 | $0.00 10-K · filed 2023-03-08 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-03-01 | |||
| 2019-12-31 | $0.00 10-K · filed 2021-03-08 | |||
| 2018-12-31 | $0.00 10-K · filed 2020-03-09 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-03-09 | |||
| 2016-12-31 | $0.00 10-K · filed 2018-03-12 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-03-12 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $0.00 derived: sum of 2 quarters · filed 2017-03-13 | $0.00 derived: sum of 3 quarters · filed 2017-03-13 | $0.00 10-K · filed 2017-03-13 |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-06 | $0.00 derived: sum of 2 quarters · filed 2014-11-06 | $0.00 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-07 | $0.00 10-Q · filed 2014-08-07 | ||
| 2013-12-31 | $0.00 10-K · filed 2015-03-26 | |||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-07 | $0.00 10-Q · filed 2014-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |